Thymidine phosphorylase (TP) is identified in higher amounts at the tumor level; thus the conversion of capecitabine to 5-fluorouracil occurs mainly at the tumor level, resulting in a low concentration of the agent in plasma or normal tissues. The gene discussed is TYMP; the disease is neoplasm.